Orginally published by The Lancet on June 1, 2017
The number of child deaths caused by diarrhea reduced by a third between 2005 and 2015, but mortality rates remain highest in some of the world’s poorest countries, with diarrhea killing almost half a million children under 5 years old each year worldwide, according to a new Global Burden of Disease study published in The Lancet Infectious Diseases journal.
The study finds that diarrhea is the fourth leading cause of death for children and responsible for 8.6% of all deaths of children aged under 5. Forty-two percent of these deaths occur in India and Nigeria alone.
“Diarrheal diseases disproportionately affect young children,” says lead author Dr Ali Mokdad, Institute for Health Metrics and Evaluation (IHME) at the University of Washington, USA. “Despite some promising reductions in mortality, the devastating impact of these diseases cannot be overlooked. Immediate and sustained actions must be taken to help low-income countries address this problem by increasing health care access and the use of oral rehydration solutions.” 
The study estimates that, in 2015, there were 2.39 billion episodes of diarrheal disease globally, with 957.5 million of these being in children. There were a total of 1.31 million deaths as a result of diarrhea globally in 2015, including 499,000 child deaths.
While mortality rates have reduced substantially (by 20.8% overall and 34.3% in children), the incidence of the disease has not reduced nearly as fast (5.9% reduction overall and 10.4% reduction in children). As a result, diarrhea still causes a significant amount of disability that mostly affects children under 5 years old.
Chad and Niger had the highest child mortality rates for diarrheal disease, with 594 and 485 deaths per 100,000 children each year, respectively. However, the largest number of deaths occurred in India and Nigeria, contributing 42% of all 499,000 child deaths in 2015 (105,000 and 103,000 deaths, respectively).
Diarrheal diseases are most common in low-income countries with poor access to clean water, sanitation, and urgent medical care, but are also a frequent cause of hospitalization in high-income countries – making diarrhea an important health problem globally.
Between 2005 and 2015, the largest reductions occurred in sub-Saharan African countries, where the mortality rate reduced by more than 100 deaths per 100,000 in western (from 445 to 277 deaths per 100,000), eastern (from 243 to 131 deaths per 100,000), and southern sub-Saharan Africa (from 214 to 113 deaths per 100,000).
Globally, unsafe water and sanitation were still the leading risk factors for diarrhea in 2015. However, better access to clean water, improved sanitation, and fewer cases of malnutrition are likely to be responsible for the reductions in mortality rates for children under 5.
Rotavirus was the main cause of diarrheal death for children, causing 146,000 deaths in 2015 despite mortality rates reducing by 44% since 2005. The authors note that this is the only cause that’s seen a reduction and this is likely to be due to the rotavirus vaccine, which had been introduced in 91 countries by March 2017. Based on this, they suggest that the development of further vaccines may be warranted – for example against cryptosporidium, which is the second biggest cause of diarrheal death for children under 5 (causing 60,400 deaths in 2015) and has few treatment options.
The researchers say that the promising reductions in mortality could be a result of better management of the diseases, and highlight how deaths of this kind are preventable if appropriate care is available.
Dr Mokdad adds: “More thorough understanding of each cause of diarrhea and how this varies geographically will help target interventions to reduce death and disability from these preventable diseases. A greater focus on vaccine development and more intentional improvements in safe water, sanitation, and hygiene will help accelerate reductions in deaths and sickness.” 
The authors note some limitations to their study, including that there is a scarcity of data in sub-Saharan Africa – where the disease burden is highest – which may mean the results are underestimated.
Writing in a linked Comment, Dr Christopher Gill, Boston University School of Public Health, USA, said: “Globally, we are making progress at reducing diarrheal disease. If we can use the GBD data also to identify areas where our data are particularly thin or dated, and so reduce uncertainties in the case of individual countries, that also would be a huge advance. As child survival researchers, we are hugely encouraged by this report, even as it reminds us that there are roughly 1.3 million excellent reasons why our job remains incomplete.”
NOTES TO EDITORS
The study was funded by the Bill & Melinda Gates Foundation. It was conducted by scientists from the Global Burden of Disease Diarrheal Diseases Collborators at the Institute for Health Metrics and Evaluation at the University of Washington.
 Quote direct from author and cannot be found in the text of the Article.
For interviews with Article author, Dr Ali Mokdad, Institute for Health Metrics and Evaluation at the University of Washington, USA, please contact: E) firstname.lastname@example.org T) +1 206 897 2800
For interviews with Comment author, Dr Christopher Gill, Boston University School of Public Health, USA, please contact: E) email@example.com T) +1 617 638 6584
For full report, visit: http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30276-1/fulltext
The Lancet journals, 125 London Wall, London EC2Y 5AS
T: +44 (0) 207 424 4249
M: +44 (0) 7920 530 997
Copyright © 2017 Elsevier Limited except certain content provided by third parties. The Lancet is a trade mark of RELX Intellectual Properties SA, used under license.